Frelaut, Maxime
du Rusquec, Pauline
de Moura, Alexandre
Le Tourneau, Christophe
Borcoman, Edith
Article History
First Online: 11 May 2020
Compliance with Ethical Standards
:
: No external funding was used in the preparation of this manuscript.
: Christophe Le Tourneau has participated in advisory boards from MSD, BMS, Merck Serono, Astra Zeneca, Roche, Novartis, Amgen, Nanobiotix, Celgene, and Rakuten. Maxime Frelaut, Pauline du Rusquec, Alexandre de Moura, and Edith Borcoman declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.